Nasal Allergy Treatment MarketThe global nasal allergy treatment market, valued at USD 6.6 billion in 2022, is expected to witness steady growth, projected to expand at a compound annual growth rate ...
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces the first participants have been dosed with OX640, an intranasal rescue medication for severe allergic reactions (incl. anaphylaxis) with ...
The affliction is hay fever and, says a new report, it is affecting more of us than ever before. Experts in immunology and allergies have calculated that more than one in four Britons is a ...
Prior to 1993, allergen immunotherapy was practiced rarely. In 1986, the Committee on Safety of Medicines (CSM) reported a series of fatalities in the UK, questioned the safety of the treatment ...